Egis World
Egis' products are sold to 100 countries around the world.
Our portfolio contains 653 products. Our main therapeutical areas are the cardiovascular system, the central nervous system and the respiratory system.
Learn moreOur activities incorporate all areas in the pharmaceutical value chain
Click here to learn moreOne of the fundamental pillars of our strategy is innovation. We devoted EUR 48 million to research and development in the 2022/2023 financial year.
Click here to learn morePlease report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, to any of the listed contacts below.